Characteristic | Heart transplant patients |
---|---|
n= 60 | |
Male sex | 34 (56.7%) |
Age (years) | 42.1± 11.5 |
Weight (kg) | 61.3 ± 13.4 |
Height (cm) | 162.5 ± 10.3 |
Body surface area (m2) | 1.7 ± 0.2 |
Primary disease | |
Chagasic cardiomyopathy | 22 (36.7%) |
Idiopathic dilated cardiomyopathy | 21 (35.0%) |
Ischemic cardiomyopathy | 7 (11.7%) |
Valvular cardiomyopathy | 5 (8.3%) |
Hypertensive cardiomyopathy | 4 (6.7%) |
CTRCD | 1 (1.6%) |
Hypertension | 12 (20.0%) |
Diabetes | 12 (20.0%) |
Smoking | 17 (28.3%) |
Time since transplantation (months) | 6 |
Medication | |
Corticosteroid | 63 (95.5%) |
Mycophenolate mofetil | 62 (93.9%) |
Tacrolimus | 45 (68.2%) |
Cyclosporine | 21 (31.8%) |
Sirolimus | 4 (6.1%) |
Azathioprine | 4 (6.1%) |
Statin | 61 (92.4%) |
CCB | 56 (84.5%) |
Betablocker | 11 (16.7%) |
ACEI/ARB | 11 (16.7%) |